Literature DB >> 11353966

Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura.

N Katkhouda1, S W Grant, E Mavor, M H Friedlander, R V Lord, K Achanta, R Essani, R Mason.   

Abstract

BACKGROUND: Splenectomy has been shown to produce long term remission in patients with immune thrombocytopenic purpura (ITP). With the development of laparoscopic splenectomy, there is renewed interest in the surgical treatment of ITP. The aim of this study was to identify factors that are predictive of outcome after laparoscopic splenectomy for ITP.
METHODS: A case series of 67 consecutive patients with ITP undergoing laparoscopic splenectomy was reviewed. A positive response was defined as a postoperative platelet count greater than 150,000/ml requiring no maintenance medical therapy on follow-up evaluation. A chi-square test and a stepwise logistic regression analysis were performed for the following variables: age, gender, preoperative response to steroids, duration of disease, severity of preoperative bleeding, accessory spleens, and thrombocytosis on discharge.
RESULTS: At a median follow-up period of 38 months (range, 2-56 months), 52 patients (78%) had a positive response to laparoscopic splenectomy. Of the 15 patients (22%) who did not have a positive response, 11 were refractory and 4 relapsed. All relapses occurred in patients with a platelet count less than 150,000/microl at discharge. Patient age was the most significant predictive factor for success or failure of the operation. The median age of the responders (31 years; range, 19-71 years) was significantly lower than the median age of the nonresponders (49 years; range, 24-62; p < 0.001). Only 5.6% of those younger than 40 years did not have a positive response, compared with 42% of patients older than 40 years (p < 0.05). Patient age was significantly associated with outcome on univariable chi-square analysis (p = 0.001), and was the only significant factor on multivariable analysis (odds ratio, 2.65; 95% confidence interval, 1.71-4.1). Other significant predictors of outcome on univariable analysis were preoperative response to corticosteroids and platelet count on discharge.
CONCLUSIONS: A long-lasting response after splenectomy for ITP is more likely to occur in patients younger than 40 years of age. To avoid the long-term side effects of corticosteroid use, early surgical referral of younger patients with ITP should be considered.

Entities:  

Mesh:

Year:  2001        PMID: 11353966     DOI: 10.1007/s004640000355

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  20 in total

1.  Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura.

Authors:  A Juliá; C Araguás; J Rosselló; J Bueno; P Domenech; M Olona; R Guardia; J Petit; A Flores
Journal:  Br J Haematol       Date:  1990-10       Impact factor: 6.998

Review 2.  Therapy for adults with refractory chronic immune thrombocytopenic purpura.

Authors:  R McMillan
Journal:  Ann Intern Med       Date:  1997-02-15       Impact factor: 25.391

3.  Is laparoscopic splenectomy a justified approach in hematologic disorders? Preliminary results of a prospective multicenter study. Belgian Group for Endoscopic Surgery.

Authors:  J F Gigot; M Legrand; G B Cadiere; G Delvaux; J de Ville de Goyet; A de Neve de Roden; E Van Vyve; P Hourlay; J Etienne; B Njinou
Journal:  Int Surg       Date:  1995 Oct-Dec

4.  High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura.

Authors:  C Law; M Marcaccio; P Tam; N Heddle; J G Kelton
Journal:  N Engl J Med       Date:  1997-05-22       Impact factor: 91.245

5.  Role of splenectomy in hematologic disorders.

Authors:  S I Schwartz
Journal:  World J Surg       Date:  1996 Nov-Dec       Impact factor: 3.352

6.  Laparoscopic splenectomy in patients with hematologic diseases.

Authors:  J L Flowers; A T Lefor; J Steers; M Heyman; S M Graham; A L Imbembo
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

7.  Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpura.

Authors:  K L Harold; R T Schlinkert; D K Mann; C B Reeder; P Noel; T R Fitch; T A Braich; J K Camoriano
Journal:  Mayo Clin Proc       Date:  1999-01       Impact factor: 7.616

Review 8.  Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients.

Authors:  N Katkhouda; M B Hurwitz; R T Rivera; M Chandra; D J Waldrep; J Gugenheim; J Mouiel
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

9.  The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy.

Authors:  Y Najean; V Dufour; J D Rain; M E Toubert
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

10.  Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): a report on 181 cases.

Authors:  P Fenaux; M T Caulier; M C Hirschauer; R Beuscart; J Goudemand; F Bauters
Journal:  Eur J Haematol       Date:  1989-03       Impact factor: 2.997

View more
  16 in total

1.  Predictive factors for platelet count after laparoscopic splenectomy in cirrhotic patients.

Authors:  Daisuke Yoshida; Yoshihiro Nagao; Morimasa Tomikawa; Hirofumi Kawanaka; Tomohiko Akahoshi; Nao Kinjo; Hideo Uehara; Naotaka Hashimoto; Makoto Hashizume; Yoshihiko Maehara
Journal:  Hepatol Int       Date:  2011-09-30       Impact factor: 6.047

2.  Laparoscopic splenectomy for immune thrombocytopenia (ITP) patients with platelet counts lower than 1 × 109/L.

Authors:  Zhong Wu; Jin Zhou; Prasoon Pankaj; Bing Peng
Journal:  Int J Hematol       Date:  2011-11-05       Impact factor: 2.490

3.  [Splenectomy for thrombocytopenic purpura. Retrospective analysis of the postoperative course].

Authors:  K Beseoglu; U Germing; W Gross-Weege
Journal:  Chirurg       Date:  2005-08       Impact factor: 0.955

4.  Laparoscopic Splenectomy for Immune Thrombocytopenic Purpura (ITP) Patients with Very Severe Thrombocytopenia.

Authors:  Shahana Gupta; Raja Kalayarasan; Sandip Chandrasekar; Senthil Gnanasekaran; Biju Pottakkat
Journal:  Indian J Hematol Blood Transfus       Date:  2017-11-25       Impact factor: 0.900

5.  Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura: study of clinical and laboratory data.

Authors:  C Balagué; S Vela; E M Targarona; I J Gich; E Muñiz; A D'Ambra; A Pey; V Monllau; E Ascaso; C Martinez; J Garriga; M Trias
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

6.  Prognostic factors of response to laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura.

Authors:  Hyuk-Chan Kwon; Chang-Hoon Moon; Young-Rak Cho; Min-Chan Kim; Kyeong-Hee Kim; Jin-Yeong Han; Young-Ho Lee; Sung-Yong Oh; Sung-Hyun Kim; Jae-Seok Kim; Hyo-Jin Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

7.  Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  B Habermalz; S Sauerland; G Decker; B Delaitre; J-F Gigot; E Leandros; K Lechner; M Rhodes; G Silecchia; A Szold; E Targarona; P Torelli; E Neugebauer
Journal:  Surg Endosc       Date:  2008-02-22       Impact factor: 4.584

8.  Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia.

Authors:  Mingjun Wang; Mengni Zhang; Jin Zhou; Zhong Wu; Ke Zeng; Bing Peng; Ting Niu
Journal:  Int J Hematol       Date:  2013-04-17       Impact factor: 2.490

9.  Long-term outcome after laparoscopic splenectomy related to hematologic diagnosis.

Authors:  C Balagué; E M Targarona; G Cerdán; J Novell; O Montero; G Bendahan; A García; A Pey; S Vela; M Diaz; M Trías
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

Review 10.  Laparoscopic splenectomy for lymphoproliferative disease.

Authors:  R M Walsh; F Brody; N Brown
Journal:  Surg Endosc       Date:  2003-12-29       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.